OUR TECHNOLOGY
01 / MODULAR
We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA).
02 / APPLICABLE
Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues and present multiple epitopes on the surface for vaccine purposes.
03 / RELIABLE
With relatively quick production time and cost, BioCapZ provides an easy-to-store nanoplatform using an icosahedral scaffold for a broad range of therapeutic and theranostic applications.

BioCapZ
Modular surface functionalization to carry targeting or tracking peptides, as well as immunogenic peptides for vaccine design.
We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA).

MEET BioCapZ
Proprietary BioCapZ™ platform based on hepatitis E viral capsid for noninvasive diagnostic and targeted therapeutic deliveries.


The BioCapZ technology was invented by Prof Holland Cheng based on the hepatitis E capsid. Prof Cheng’s laboratory has engineered the viral capsid to package a wide range of molecules from small molecules to large biological molecules as proteins and nucleic acids (DNA and RNA). Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues as well as to present multiple epitopes on the surface for vaccine purposes